Method of treating fulminant hepatic failure using DLL4 cytokine
A method of treating fulminant hepatic failure in a subject, includes administering a therapeutically effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a DLL4 cytokine. A method of treating liver failure, sub-acute liver failure, chronic liver failure or acute-on-chronic liver failure in a subject, includes administering an therapeutically effective amount of a DLL4 cytokine to the subject.
Zhejiang University
A A
A61K A61K
inventional inventional
Jun Lanjuan Jiang Xin
Li Li Li Chen